Deborah Tannehill
Family · Fort Wayne, INNPI 1437306990
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 404 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 50.0% of the total. Reporting peaked in 2023 at $3,399 and has fallen 77.6% since, to $761 in 2025. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 404 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Nestle Healthcare Nutrition Inc.$573
- Takeda Pharmaceuticals U.S.A., Inc.$508
- AstraZeneca$471
- Gilead$358
- Sanofi-aventis U.S. LLC$319
- plus $3K from 28 others
What the payments were for
- Food & beverage$10,339100%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 244 | $5,184 |
| Nestle Healthcare Nutrition Inc. | 36 | $573 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $508 |
| AstraZeneca(2 entities) | 4 | $471 |
| Gilead | 14 | $358 |
| Sanofi-aventis U.S. LLC | 3 | $319 |
| Johnson & Johnson | 25 | $311 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $228 |
| Enterra Medical, Inc. | 2 | $213 |
| Sanofi | 2 | $193 |
| Argenx US, Inc. | 1 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Daiichi Sankyo Inc. | 1 | $124 |
| Amgen | 1 | $122 |
| Scynexis, Inc. | 1 | $119 |
| Neurocrine Biosciences, Inc. | 1 | $115 |
| Biogen | 1 | $113 |
| Corcept Therapeutics | 1 | $102 |
| Novo Nordisk | 1 | $99 |
| Lundbeck LLC | 1 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Tactile Systems Technology Inc | 2 | $89 |
| E.r. Squibb & Sons, L.L.C. | 2 | $83 |
| Exact Sciences | 1 | $82 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $80 |
| Ironwood Pharmaceuticals, Inc | 5 | $73 |
| Medtronic | 1 | $68 |
| Intercept Pharmaceuticals, Inc. | 4 | $66 |
| Pfizer | 4 | $56 |
| QOL Medical, LLC | 3 | $54 |
| Bristol Myers Squibb | 3 | $51 |
| Vivus LLC | 2 | $29 |
| Merck | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,371 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 65 | $616 |
| Omeprazole | 25 | $228 |
| Famotidine | 17 | $188 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Wayne
- Justin BrownFort Wayne$142K
- Tracy JohnsonFort Wayne$68K
- Grant BlauveltFort Wayne$28K
- Benjamin GiarmoFort Wayne$21K
- Katarzyna SedlaczekFort Wayne$20K
- Brandy DantzerFort Wayne$18K
- Catherine RobertsFort Wayne$13K
- Adam ZuberFort Wayne$13K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.